| Top 10 cancer sites in the study | Site (ICD-10) | Study (n = 7106) | Globocan 2012 (n = 1,852,718) | ||
| No. of new cancer cases | Percent | No. of new cancer cases | Percent | ||
| 1 | Breast (C50) | 1423 | 20.0% | 255,881 | 13.8% |
| 2 | Cervix uteri (C53) | 772 | 10.9% | 154,296 | 8.3% |
| 3 | Lip, oral cavity and pharynx (C00-C14) | 562 | 7.9% | 146,929 | 7.9% |
| 4 | Lung (C33-C34) | 489 | 6.9% | 155,081 | 8.4% |
| 5 | Colorectum (C18-C21) | 469 | 6.6% | 135,546 | 7.3% |
| 6 | Prostate (C61) | 349 | 4.9% | 125,049 | 6.7% |
| 7 | Corpus uteri (C54) | 294 | 4.1% | 26,646 | 1.4% |
| 8 | Thyroid (C73) | 258 | 3.6% | 40,484 | 2.2% |
| 9 | Larynx (C32) | 254 | 3.6% | 39,892 | 2.2% |
| 10 | Stomach (C16) | 244 | 3.4% | 112,346 | 6.1% |